Voya Investment Management LLC Sells 1,720,883 Shares of CVS Health Corporation $CVS

Voya Investment Management LLC lessened its stake in shares of CVS Health Corporation (NYSE:CVS) by 80.9% during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 405,702 shares of the pharmacy operator’s stock after selling 1,720,883 shares during the period. Voya Investment Management LLC’s holdings in CVS Health were worth $30,586,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of CVS. Norges Bank bought a new position in CVS Health during the second quarter valued at $1,358,698,000. Dodge & Cox boosted its stake in shares of CVS Health by 4.8% during the 1st quarter. Dodge & Cox now owns 73,459,122 shares of the pharmacy operator’s stock worth $4,976,856,000 after purchasing an additional 3,353,223 shares during the period. Invesco Ltd. grew its holdings in CVS Health by 15.3% during the 2nd quarter. Invesco Ltd. now owns 23,532,479 shares of the pharmacy operator’s stock valued at $1,623,270,000 after purchasing an additional 3,118,626 shares during the last quarter. Robeco Institutional Asset Management B.V. raised its position in CVS Health by 815.2% in the 2nd quarter. Robeco Institutional Asset Management B.V. now owns 2,663,111 shares of the pharmacy operator’s stock worth $183,701,000 after purchasing an additional 2,372,121 shares during the period. Finally, Kingstone Capital Partners Texas LLC bought a new stake in CVS Health in the second quarter worth about $155,185,000. 80.66% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

CVS has been the subject of several recent analyst reports. Wall Street Zen lowered CVS Health from a “buy” rating to a “hold” rating in a research report on Saturday, November 1st. Cantor Fitzgerald restated an “overweight” rating on shares of CVS Health in a report on Wednesday, December 10th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of CVS Health in a research report on Monday, December 15th. Raymond James Financial lifted their target price on CVS Health from $75.00 to $90.00 in a research report on Friday, October 31st. Finally, Leerink Partners upped their price target on shares of CVS Health from $86.00 to $95.00 and gave the stock an “outperform” rating in a report on Thursday, October 16th. Two equities research analysts have rated the stock with a Strong Buy rating, twenty have given a Buy rating and four have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $94.67.

CVS Health Price Performance

CVS opened at $77.70 on Friday. The company has a market capitalization of $98.63 billion, a price-to-earnings ratio of 204.47, a PEG ratio of 0.77 and a beta of 0.48. The company has a current ratio of 0.83, a quick ratio of 0.63 and a debt-to-equity ratio of 0.83. CVS Health Corporation has a 12-month low of $43.56 and a 12-month high of $85.15. The business’s fifty day simple moving average is $79.09 and its 200-day simple moving average is $72.43.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share for the quarter, beating the consensus estimate of $1.36 by $0.24. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.The firm had revenue of $102.87 billion during the quarter, compared to the consensus estimate of $98.85 billion. During the same period in the previous year, the company posted $1.09 earnings per share. The firm’s quarterly revenue was up 7.8% on a year-over-year basis. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. On average, equities research analysts anticipate that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.